Today: 20 May 2026
Experian share price: why EXPN steadied on Friday and what could move it next week
24 January 2026
1 min read

Experian share price: why EXPN steadied on Friday and what could move it next week

London, Jan 24, 2026, 08:50 GMT — Markets have shut down.

Experian’s shares nudged up 0.4% to 3,029 pence on Friday, snapping a two-day losing streak. About 2.37 million shares traded hands. The stock remains just above its 52-week low, with the ex-dividend marker visible on screens.

This matters because the recent dip isn’t just a one-day blip. Investors face a bigger question: Is the North American credit cycle shifting for good, or merely taking a breather? And how much earnings growth can Experian’s fraud and identity services actually deliver if lenders remain on edge?

The group’s update earlier this week kept its core message intact but shifted the short-term sentiment. Credit bureaus often move like macro stocks, reacting sharply to changes in rate forecasts and fluctuations in mortgage demand.

Experian reported a 12% revenue increase at actual exchange rates for the quarter, or 10% on a constant currency basis. Organic revenue growth stood at 8%, excluding currency fluctuations and acquisitions. North America, which makes up 68% of the group’s revenue, saw 10% organic growth. CEO Brian Cassin described the results as “strong Q3 growth” and confirmed the company’s full-year outlook remains unchanged. experianplc.com

Shares plunged to a 19-month low following the update, tumbling as much as 7% on Wednesday, Reuters reported. Andrew Ripper, analyst at Panmure Liberum, highlighted several headwinds: a weaker U.S. dollar, a proposed 10% cap on credit card interest rates in the U.S., and Fair Isaac’s move to sell credit scores directly to mortgage lenders. During the post-update call, Experian noted that if the credit-card rate cap passes, the main fallout would likely hit U.S. consumers.

Matt Britzman, senior equity analyst at Hargreaves Lansdown, said in a separate note that the “price reaction on the day felt a little harsh.” He added that expectations might have been edging up ahead of the update. Hargreaves Lansdown

Investors are eyeing a couple of key dates ahead, with little new company news to digest. Experian’s first interim dividend hits on Feb. 6, while the full-year results are scheduled for release on May 20.

Focus in the sector is shifting to U.S. peers for clues. Equifax plans to release its fourth-quarter results on Feb. 4, a report that could influence sentiment on credit-check and fraud-screening activity as February begins.

Yet, risks are obvious. Should U.S. lenders continue to tighten, mortgage inquiries remain weak, or regulatory scrutiny over consumer credit pricing intensifies, the model’s volume-sensitive components could take a hit fast. The stock has already demonstrated vulnerability, dropping sharply on negative headlines.

The upcoming U.S. Federal Reserve meeting on Jan. 27-28 is a key date traders are eyeing. Rate expectations from this gathering directly influence loan demand and mortgage activity — and, in turn, the credit checks that Experian provides.

Stock Market Today

  • Tesla Q1 2026 Earnings Beat; Stock Faces Mixed Outlook for 2030
    May 20, 2026, 10:24 AM EDT. Tesla (TSLA) reported Q1 2026 earnings per share (EPS) of $0.41, exceeding the $0.36 consensus, with automotive gross margin rising to 21.1% from 16.2%. Operating income increased 135.8% year-on-year (YoY), and services plus Full Self-Driving (FSD) revenue jumped 42% to $3.75 billion, with 1.28 million active FSD subscriptions up 51%. Despite strong fundamentals, Tesla shares fell 8.83% year-to-date to $409.99 amid skepticism about AI monetization and scaling autonomy. Wall Street's average target is about $412, while a proprietary model estimates a base case price of $510 by 2030, with a bull case of $645. Achieving $650 requires significant price-to-earnings multiple expansion or sharp EPS growth from AI ventures, amid challenges like increased operating expenses and production constraints.

Latest articles

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

POET Technologies Jumps After $400M AI Photonics Raise, Dilution Questions Linger

20 May 2026
POET Technologies shares rose 11% to $14.55 in early Nasdaq trading Wednesday after closing a US$400 million direct offering of 19 million shares and warrants. The rebound followed an 8% drop Tuesday on dilution concerns. The company reported Q1 revenue of $503,389 and a net loss of $12.3 million. A recent $50 million order from Lumilens could scale to $500 million over five years if production ramps up.
Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

Nokia’s U.S. Broadband Order Arrives While AI-Driven Gains Test Supply Chain

20 May 2026
Nokia shares rose 3.37% in Helsinki trading Wednesday after the FCC conditionally approved its Beacons and ONT devices, exempting them from U.S. Covered List restrictions. Nokia also transferred 975,289 treasury shares to equity plan participants. Dell’Oro Group forecasts the optical transport equipment market will grow 16% in 2026, driven by AI data centers.
Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

Apellis Shares Disappear After Biogen’s $5.6 Billion Buy—One Play Left

20 May 2026
Biogen completed its acquisition of Apellis Pharmaceuticals, removing APLS shares from Nasdaq and paying investors $41 per share plus a contingent value right tied to Syfovre sales. Apellis shareholders tendered 82.4% of outstanding stock before the offer expired May 13. Biogen shares rose 0.9% to $192.34 Wednesday. The CVR could pay up to $4 if Syfovre meets future sales targets.
SGX stock rises as board-lot revamp plan lands; investors eye Feb 5 results
Previous Story

SGX stock rises as board-lot revamp plan lands; investors eye Feb 5 results

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings
Next Story

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings

Go toTop